Phreesia Health (PHR): Forward Price-to-Revenue Multiple

Public company logo of Phreesia, Inc. (PHR)

Phreesia, Inc. (PHR) generates revenue through corporate clinic subscriptions and targeted medicine. The expected market cap-to-revenue ratio on the GURU.Markets platform chart illustrates valuation dynamics, where the 0.40 mark indicates the multiplier level. A stable cloud infrastructure combined with deep software integration into medical staff workflows guarantees long-term customer loyalty and a sustainable cash flow.

Phreesia - PHR Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Phreesia Health (PHR)

- current price and projected stock value:
Comprehensive company analysis:PHR (Phreesia)
Product sample of phreesia.com

Assessing the fundamental value of an asset requires analyzing the ratio between the market price and expected cash flows. This indicator compares current capitalization with projected sales volume to determine the extent of the premium paid for future growth. By tracking changes in the forward P/S, an investor can gauge market expectations regarding revenue scaling. For Phreesia, Inc. (PHR), this reflects the expansion potential of its B2B patient intake automation platform within the US healthcare software market.

Direct competitors

Forward P/S Multiple VEEV (Veeva)|Forward P/S Multiple Doximity Inc DOCS|HQY: Forward Price-to-Revenue Multiple|Forward Price to Sales WAY (Waystar Corp)|CRVL: Forward P/S Multiple|PRVA - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Huron|Market Cap to Projected Revenue CERT (Certara Inc)|Forward P/S Multiple OMCL|Forward Price-to-Revenue Multiple GoodRx Gold GDRX|Schrodinger, Inc. - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio omadahealth.com (OMDA)|EVH - Price-to-Projected Revenue Ratio|Future Price to Revenue HSTM|DH: Forward P/S Multiple|Consensus Corp - Forward Price to Sales|Price-to-Projected Revenue Ratio Agilon Health|ABSI: Forward Price to Sales|Forward P/S Multiple SY|Market Cap to Expected Sales Ratio NRC Health|Spok Corp - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio OPRX (OptimizeRx Inc.)|TBRG: Forward Price-to-Revenue Multiple|Forward Price to Sales SLP (simulations-plus.com)|sophiagenetics.com (SOPH) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Health Catalyst Inc.|CCLD (CareCloud Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Research Solutions Inc. RSSS|Forward P/S Multiple DLHC|onemednet.com - Market Cap to Projected Revenue|Price-to-Projected Revenue Ratio Scienture SCNX|HCTI (Healthcare Triangle Inc) - Future Price to Revenue|iSpecimen Corp - Forward P/S Multiple|Forward Price to Sales BFRG (Bullfrog AI Holdings)|SCWorx Corp. (WORX) - Price-to-Projected Revenue Ratio|msprecovery.com - Forward Price to Sales|ICCT (iCoreConnect, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio TRxADE HEALTH Inc MEDS|Forward P/S Multiple ORGS|RCM - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Sharecare, Inc. SHCR|Market Cap to Expected Sales Ratio streamlinehealth.net (STRM)|Syra Health - Forward P/S Multiple|Market Cap to Expected Sales Ratio Apollo Medical Holdings AMEH|MODN: Forward P/S Multiple|NextGen Healthcare Corp (NXGN) - Forward P/S Multiple